RDIF announces Sputnik V efficacy data from San Marino
The Russian Direct Investment Fund (RDIF) yesterday announced new positive real-world data of the Ministry of Health of the Republic of San Marino on efficacy of the Russian Sputnik V vaccine...
November 26, 2021
by ExpressPharma
Interim Results Of A Pioneering Combination Study In Argentina With More Than 1,000 Participants Confirm The One-shot Sputnik Light Vaccine (The First Component Of The Sputnik V Vaccine) Is An Effecti
The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund) announces the interim results of the study in Argentina on heterogeneous regimens combining Sputnik Light ...
October 15, 2021
by prnasia
AstraZeneca and Sputnik V combination show no adverse events: RFID
The world’s first study of a combination between the AstraZeneca vaccine and the first component of the Sputnik V vaccine (Sputnik Light) in Azerbaijan shows no serious adverse events or COVID infection cases following the vaccination.
August 2, 2021
by expresspharma
Sputnik V vaccine production in India to go fully on stream in September: RDIF
The Russian Direct Investment Fund (RDIF) said that production of the Sputnik V COVID-19 vaccine in India is expected to start in September, The Economic Times reported Sunday.
August 2, 2021
by firstwordpharma
First batches of the Sputnik V vaccine produced in Uzbekistan by Jurabek Laboratories
RDIF, Russia's sovereign wealth fund, and one of the leading pharmaceutical companies of Uzbekistan, Jurabek Laboratories, today announced the first batches of the Russian Sputnik vaccine against coronavirus have been produced at company's facilities.
August 2, 2021
by firstwordpharma
Serum Institute to start manufacturing Sputnik vaccine in September
The first batch of Sputnik vaccine is expected to be produced at SII's facilities in September, RDIF said.
July 14, 2021
by expresspharma
SII to commence manufacturing of Sputnik COVID-19 vaccine in September
As per the agreement between RDIF and SII, the parties intend to produce over 300 million doses of the vaccine in India per year.
July 14, 2021
by expresspharma
RDIF and Morepen Laboratories announce test batch manufacturing of Sputnik V in India
The Russian Direct Investment Fund (RDIF) and Morepen Laboratories announced the production of the test batch of the Russian Sputnik V coronavirus vaccine in an exclusive facility in the state of Himachal Pradesh (HP).
July 7, 2021
by expresspharma
RDIF: Test batch of the Sputnik V vaccine produced in Mexico
The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund) and Mexican pharmaceutical company Laboratorios de Biológicos y Reactivos de México (BIRMEX) announce the production of a test batch of the Russian Sputnik V vaccine against corona
July 6, 2021
by firstwordpharma
RDIF: Sputnik V has demonstrated 97.8% efficacy against COVID cases and 100% efficacy against severe cases of COVID in UAE
The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund) announces the data of UAE's Ministry of Health on the Russian Sputnik V coronavirus vaccine confirming its safety and high efficacy during the vaccination campaign.
June 30, 2021
by prnewswire
S Korean consortium to produce Russia’s Sputnik Light vaccine
Huons Global said that its South Korean consortium plans to begin production of a single-dose Sputnik Light COVID-19 vaccine from as early as September.
June 29, 2021
by expresspharma
Test batch of the Sputnik V vaccine produced in Iran
The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), and Actoverco, one of Iran’s leading pharmaceutical companies, announce the production of a test batch of the Russian Sputnik V vaccine against coronavirus.
June 28, 2021
by firstwordpharma